Literature DB >> 4129833

Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.

M S Drapkin, E Appella, L W Law.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4129833     DOI： 10.1093/jnci/52.1.259

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Subcellular Localization of simian virus 40 large tumor antigen.

Authors:  H R Soule; J S Butel
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

2.  Expression of tumor-specific transplantation antigen in cell lines transformed by wild-type of tsA mutant simian virus 40.

Authors:  C Chang; J L Anderson; R G Martin; P T Mora
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

3.  Expression and thermal stability of simian virus 40 tumor-specific transplantation antigen and tumor antigen in wild type- and tsA mutant-transformed cells.

Authors:  J L Anderson; C Chang; P T Mora; R G Martin
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

4.  Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells.

Authors:  C Chang; R G Martin; D M Livingston; S W Luborsky; C P Hu; P T Mora
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

5.  T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo.

Authors:  C M Henningsson; S Selvaraj; G D MacLean; M R Suresh; A A Noujaim; B M Longenecker
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.

Authors:  M Glaser
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

7.  Minor histocompatibility antigens do not enhance BALB/c anti-SV40 TASA response.

Authors:  P Nanni; C de Giovanni; M C Galli; S Grilli; P L Lollini; G Nicoletti; G Prodi
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.